Glooko logo

Glooko In the News

Select A Year
Clear
April 12, 2023

Diabetes company Glooko partners with insulin dosing app Hedia

Through a new partnership, the Hedia app, which provides bolus insulin dosing recommendations, will integrate with Glooko’s connected care platform,...

Read More

April 11, 2023

Glooko adds insulin dosing recommendations to diabetes management app with Hedia collab

In addition to gathering data from glucose monitors, insulin pumps, fitness trackers and other devices, Glooko’s diabetes management platform will offer...

Read More

March 15, 2023

The connected care horizon in 2023

2023 is expected to be a year of advancements in connected care supporting patients with chronic conditions and their care teams. Glooko CEO Russ Johannesson...

Read More

March 6, 2023

Smart Insulin Pens: How They Work, And Your Experiences of Using Them

Smart insulin pens are a recent advancement making an impact on people living with diabetes. These connected pens can be used by anyone with the chronic...

Read More

February 24, 2023

Sanofi boosts ‘connected insulin’ push with Glooko deal

Sanofi formed a partnership with Glooko to support its vision of insulin-based therapies connected with glucose monitoring devices that simplify blood...

Read More

February 23, 2023

Glooko, Sanofi partner on insulin pen connectivity

Glooko entered into a partnership with Sanofi to integrate a connected cap for smart insulin pens into its digital platform for people with diabetes and...

Read More

February 23, 2023

Glooko, Sanofi Partner for SoloStar Pen Connectivity with New Device SoloSmart

A new alliance between Glooko and Sanofi allows for visualization of connected pen data in the Glooko app that patients with diabetes can share with their...

Read More

February 6, 2023

Glooko picks up security certification for diabetes patient management platform

Glooko achieving ISO 27001 certification allows the digital health company to assure patients with diabetes and related chronic conditions that their health...

Read More

February 1, 2023

2023 Tech Trends: Why Digital Health Will Lead to Improved Patient Care

Wearable technologies that were built for fitness have evolved and now have greater diagnostic and medical uses. Glooko Chief Executive Officer Russ Johannesson...

Read More

August 18, 2022

Remote Patient Monitoring: It’s Easier Than You Think

Remote patient monitoring is likely to become as essential to healthcare as mobile phones are to modern life. Glooko Chief Commercial Officer Zach Henderson...

Read More

July 18, 2022

The Water’s Fine: Consider Jumping Into Remote Patient Monitoring

Glooko Chief Commercial Officer Zach Henderson shares the clinical and financial benefits of healthcare providers, health systems and payers leveraging...

Read More

July 14, 2022

Glooko AB Expands Academy Medical Education Program into Ireland

The expansion of Academy™, a free educational programme from Glooko and the Diabetes Technology Network/Association of British Clinical Diabetologists,...

Read More

July 13, 2022

Glooko Launches Diabetes Medical Education Academy in Ireland

Glooko announced, in partnership with the Diabetes Technology Network/Association of British Clinical Diabetologists, the expansion into Ireland of Academy™,...

Read More

July 4, 2022

Building Digital Platforms To Bridge Diabetes Care Gaps

Device-integrating digital health platforms, like Glooko, help bridge diabetes care gaps and enable patients to better manage their condition.

Read More

June 29, 2022

Medidata Announces Rapid Expansion of its Sensor Cloud Network with the Addition of 10 Health Technology Innovators

Medidata announced ten highly innovative organizations, including Glooko, have joined its groundbreaking Sensor Cloud Network. The company is making it...

Read More

June 21, 2022

PopHealth Week: Meet Glooko Chief Medical Officer Mark Clements, M.D., Ph.D.

Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. discussed the impact of diabetes on public health in the U.S. and how digital health platforms...

Read More

May 29, 2022

Sharper data collection is key to better insurance CX

Glooko’s remote patient monitoring solution allows healthcare providers at Atrius Health to view vast quantities of patient data and monitor a patient’s...

Read More

May 27, 2022

THCB Spotlight: ​​Russ Johannesson, CEO at Glooko

Glooko CEO Russ Johannesson brings Founder and Publisher Matthew Holt up to speed on how the connected care company has expanded globally, made strategic...

Read More

May 9, 2022

Spotlight On: Taking the friction out of diabetes management

At ATTD 2022, Glooko CEO Russ Johannessen shares insights with Executive Editor Tina Tan about how AI and other technologies can enable better and more...

Read More

May 4, 2022

Academy™: An Online Diabetes Educational Programme for Healthcare Professionals

Chair of the Diabetes Technology Network UK Dr. Pratik Choudhary outlines the development of Academy™, a free CPD accredited online educational programme,...

Read More

April 20, 2022

The 6 Factors of Success: How Digital Diabetes Management Solutions set an example for others

Successful digital diabetes platform vendors, like Glooko, are aware of the needs of healthcare providers and offer advanced population management solutions...

Read More

April 7, 2022

The 2022 HealthTech Brand Check

In an era of health fads and medical disinformation, building a business on evidence-led, authoritative information is more important than ever. Glooko...

Read More

April 7, 2022

Glooko’s Role in Revolutionizing Diabetes Data Usability

Diabetes technology and data sharing capabilities have come an incredibly long way, and Glooko has helped lead the way. This retrospective explores Glooko’s...

Read More

April 4, 2022

At-Home Digital Health Innovations Transforming Diabetes Care

Glooko Chief Medical Officer Mark Clements, M.D., Ph.D. discusses why remote patient monitoring and other at-home digital health innovations are becoming...

Read More

April 1, 2022

The Future of Telehealth and Technology Supporting It

Glooko CEO Russ Johannesson discusses the different interpretations of telehealth, the rapid development and adoption of telehealth during COVID-19 and...

Read More

March 30, 2022

Terumo, Glooko partner for diabetes data sharing with insulin patch pump

Terumo and Glooko announced a collaboration to integrate their technologies and create new diabetes data sharing solutions.

Read More

March 24, 2022

Exec Chat: Glooko CEO Talks Differentiation, Collaboration & The Future Of Digital Diabetes Solutions

Glooko CEO Russ Johannesson discusses the company’s connected diabetes care strategy, including its recent agreement with Johns Hopkins HealthCare Solutions...

Read More

March 17, 2022

Glooko picks up DIABNEXT to launch digital diabetes management platform in France

In its second acquisition of 2022 so far, Glooko is forging ahead in its mission not only to bulk up its digital diabetes management offerings but also...

Read More

March 16, 2022

M&A, Data & Big Approvals Are Defining Diabetes Tech in 2022

Glooko is the latest newsmaker for diabetes tech – as the company is quickly hopping back on the M&A trail after the xBird deal in February. Glooko...

Read More

March 16, 2022

Glooko acquires fellow diabetes management company DIABNEXT

Digital diabetes management company Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform.

Read More

March 16, 2022

Glooko acquires DIABNEXT and its digital health platform for managing diabetes

Glooko announced that it acquired DIABNEXT, a developer of a digital health platform for managing diabetes and connecting to healthcare providers.

Read More

February 1, 2022

A proliferation of partnerships for platform plays

Glooko acquires xbird, a company developing AI-driven just in time adaptive interventions.

Read More

February 1, 2022

Glooko’s CEO expects to provide more personalized recommendations to users following German AI acquisition

Digital health company Glooko acquired xbird, a medical AI company with Just In Time Adaptive Intervention technologies to predict patient behavior and...

Read More

January 31, 2022

Glooko adds AI to its digital diabetes tools with xbird takeover

Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients and has now added artificial intelligence...

Read More

January 31, 2022

Glooko acquires AI-enabled diabetes management company xbird

Digital diabetes and chronic condition management company Glooko announced it had acquired Berlin-based xbird, maker of AI-based diabetes care tools.

Read More

January 31, 2022

Glooko adds AI-powered coaching to its digital diabetes management tools with Xbird acquisition

Adding Xbird’s machine learning software will help the Glooko platform better predict patients’ behavior and improve how they manage their diabetes...

Read More

January 31, 2022

Glooko Keeps Diabetes Management Space Hot with M&A

Glooko is dipping into the field of artificial intelligence and machine learning with its acquisition of xbird.

Read More

January 14, 2022

Cardiometabolic Syndrome: Overlooked & Poised to Boom as Digital Tech Peaks

At Biotech Showcase 2022, Glooko COO Komathi Stem discussed how real world data, digital platforms and AI help pharmaceutical companies create therapies...

Read More

January 12, 2022

How Interoperability, Increased Reimbursement Options Will Drive Digital Health In 2022

Glooko CEO Russ Johannesson predicts that the growth in digital health funding will continue in 2022, and that the push toward interoperability will be...

Read More

January 12, 2022

Interoperability Is ‘Critical’ To Making Digital Health Tools More Valuable In 2022

Russ Johannesson, CEO of diabetes management company Glooko, looks back on the trends in digital health last year—including the explosion of funding—and...

Read More

January 10, 2022

Continuous Glucose Monitoring: How It’s Advancing Diabetes Care

Glooko was included in a report that highlights the burgeoning industry of continuous glucose monitoring and where it’s likely to head next.

Read More

December 14, 2021

Diabetes Digital Therapeutics for Healthcare Payers — ESP Vendor Matrix

Glooko was named a leader in diabetes digital therapeutics for healthcare payers by CB Insights. The ranking reinforces the company’s commitment...

Read More

December 1, 2021

How Technologies Are Personalizing At-Home Diabetes Care

Seemingly overnight, healthcare discovered and fully embraced digital health solutions. Just months after the 2020 nationwide lockdown, telehealth visits,...

Read More

November 12, 2021

Remote Patient Monitoring: A Platform for Innovations in Interdisciplinary Care Management

The aftershocks of COVID-19 continue to reverberate throughout the U.S. healthcare system. For example, the pandemic has forever dispelled the quaint notion...

Read More

October 18, 2021

Commercializing Digital Therapeutic Solutions: Key Lessons Learned to Watch

The pandemic has set ablaze the white-hot market for Digital Therapeutics (DTx), which “deliver medical interventions directly to patients using evidence-based,...

Read More

September 1, 2021

Misconceptions and Truths about Remote Patient Monitoring

In recent years, there has been a great deal of talk in healthcare circles about remote patient monitoring (RPM), a trend that has only accelerated over...

Read More

August 31, 2021

Glooko’s Remote Patient Monitoring for People with Diabetes

In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Russ Johannesson,...

Read More

June 26, 2021

ADA 2021 Study Outlines Benefits of RPM on Glycemic Control in Patients with Type 2 Diabetes

A study assessing use of remote patient monitoring in patients with type 2 diabetes outlines the impact continued participation in digital monitoring programs...

Read More

June 25, 2021

ADA21: Glooko Study Finds Diabetes Remote Monitoring Helps Keep Glucose Levels in Check

According to study findings presented by Glooko at the American Diabetes Association (ADA) scientific sessions on Friday, remote patient monitoring (RPM)...

Read More

June 23, 2021

Lilly inks smart insulin pen deals with Roche, Dexcom and more

The company aims to secure a CE mark for the Tempo Smart Button by the end of this year, enabling it and the Tempo Pen to be sold as a single package in...

Read More

May 7, 2021

Glooko, Eli Lilly to Collaborate on Connected Insulin Pens

Glooko will partner with Eli Lilly for a strategic digital health collaboration using Eli Lilly’s connected insulin pens, the Tempo Pen and Tempo Smart...

Read More

April 30, 2021

Russ Johannesson on Setting the Pace in Digital Health

To make sure its upcoming connected insulin pen system will work with the user’s choice of daily diabetes management platforms, Eli Lilly & Co. has...

Read More

April 20, 2021

The Modernization of Clinical Trials: COVID-19’s Lasting Impact

In 2015, the Clinical Trial Transformation Initiative (CTTI) recommended that trial sponsors consider fully or partially decentralized DCTs, defined as...

Read More

April 15, 2021

Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19

As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an...

Read More

April 1, 2021

How Glooko improves health outcomes by connecting people with diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and better collaboration! Interview with Zach Henderson, Chief Commercial Officer at Glooko

COVID-19 has changed the way healthcare is delivered and has rapidly affected the virtual care adoption and usage. To manage better their day-to-day routine...

Read More

March 25, 2021

The startup behind a COVID-19 vaccine gears up for an IPO

The pandemic has turned lesser-known biopharmaceutical startups into household names, including vaccine developers Moderna and BioNTech. Now the company...

Read More

March 16, 2021

Diabetes management startup Glooko collects $30M to push remote monitoring, new therapy areas

Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health...

Read More

March 16, 2021

Investors Ride High on the Telehealth Wave

One of the growing trends in the medtech industry is the rapid adoption of remote patient monitoring/telehealth. Glooko’s latest financing round is an...

Read More

March 1, 2021

The COVID-19 effect: Research platforms require new capabilities

With a shift to virtual/decentralized clinical trials, the popularity of decentralized clinical trials (DCTs) skyrocketed following the nationwide lockdown...

Read More

February 1, 2021

2021: Technology Trends and the Future of Medical Devices

While the far-reaching effects of COVID-19 have introduced the world to a “new normal,” the greatest impact has been in healthcare. In the long term,...

Read More

November 13, 2020

Exec Chat: How Glooko Plans To Ride Digital Health Care Wave To Profitability

In an interview with Medtech Insight, Glooko CEO Russ Johannesson outlines the company’s growth opportunities, expansion plans beyond diabetes and financing...

Read More

April 21, 2020

Life science companies combine to form COVID-19 research database

A group of major CRO, life science, data analytics, publishing and healthcare companies, including Glooko, joined forces to release a pro bono research...

Read More

April 11, 2020

Glooko collaborates with Association of British Clinical Diabetologists on education programme

US-based diabetes software app, Glooko has announced a partnership with the Association of British Clinical Diabetologists (ABCD) / Diabetes Technology...

Read More

March 24, 2020

Healthcare professionals offered free remote software to aid diabetes community

A leading diabetes software company is taking action to serve the global diabetes community amid the current COVID-19 pandemic and offering a free, remote...

Read More

March 19, 2020

Remote Care, Easy Refills Help People with Diabetes During COVID-19

As America and the rest of the world grapples with the escalating global coronavirus pandemic of 2020, healthcare providers are transitioning to remote...

Read More

February 12, 2020

Glooko’s newest executives, Aetion’s cross-industry data expert and more digital health hires

Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis...

Read More

May 21, 2019

Glooko Appoints Dr. Mark Clements as Chief Medical Officer

Glooko, a provider of diabetes data management solutions, announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr....

Read More

May 6, 2019

Glooko partners with T1D Exchange

Glooko’s diabetes management platform will be used to incorporate data from devices like insulin pumps, CGMs and glucometers into the T1D Exchange...

Read More